AstraZeneca plc (ADR) (NYSE:AZN) rejected the huge deal of $101 billion that was offered by Pfizer Inc. (NYSE:PFE) as an attempt to take over the British Drug Company. AstraZeneca plc (ADR) (NYSE:AZN) shares after opening at $68.00 moved to $68.07 on last trade day and at the end of the day closed at $67.78. Company price to sales ratio in past twelve months was calculated as 3.33 and price to cash ratio as 8.54. AstraZeneca plc (ADR) (NYSE:AZN) showed a positive weekly performance of 8.41%.
Novartis AG (ADR) (NVS) announced plans to overhaul its business. The company plans to sell two units and buy another, in multiple transactions totalling $25 billion, which have the potential to increase to as much as $28.5 billion. Novartis AG (ADR) (NYSE:NVS) shares fell -0.45% in last trading session and ended the day on $86.17. NVS return on equity ratio is recorded as 13.00% and its return on assets is 7.40%. Novartis AG (ADR) (NYSE:NVS) yearly performance is 21.64%.
The maker of Horlicks and Boost brands, GlaxoSmithkline plc (ADR) (NYSE:GSK) Consumer Healthcare, has kept its Indian consumer healthcare business out of its recently signed global JV agreement with Swiss major Novartis AG. On April 22, 2014. GlaxoSmithKline plc (ADR) (NYSE:GSK) shares moved down -0.29% in last trading session and was closed at $55.14, while trading in range of $54.96 – $55.52. GlaxoSmithKline plc (ADR) (NYSE:GSK) year to date (YTD) performance is 4.67%.
Leave a Reply